16 Days of Activism 2025: A Call to End Gender-Based Violence

Nov 24, 2025 | Non classé

From 25 November to 10 December each year, the global community highlights the 16 Days of Activism Against Gender-Based Violence – a period dedicated to raising awareness, driving action and engaging all sectors of society to prevent and respond to violence rooted in gender.

What is this campaign?

The 16 Days campaign begins on International Day for the Elimination of Violence Against Women and ends on Human Rights Day. It was launched in 1991 by activists at the inaugural Women’s Global Leadership Institute and has since been adopted by thousands of organisations worldwide. The campaign emphasises that violence against women and girls is both a human-rights violation and a barrier to development, equality and peace.

Why it matters
  • Globally, about 1 in 3 women experience physical and/or sexual violence in their lifetime
  • In crises, such as conflict, displacement, pandemics, risks of gender-based violence escalate, while access to support services often shrinks
  • Violence rooted in gender inequality not only harms individuals, but also undermines families, communities and societies at large
  • Responsiveness matters: Without accessible support, legal protection and cultural change, survivors may remain unsupported and perpetrators unaccountable
What the focus covers

Physical, sexual and psychological violence

Intimate partner violence, non-partner sexual assault, harassment and threats.

Harmful practices

Child marriage, female genital mutilation, forced marriage, trafficking in persons.

Digital gender-based violence

Online harassment, image-based abuse, cyber-harassment of women and girls.

Intersectional & crisis contexts

Women and girls in emergencies or conflict zones, displaced persons, and marginalised groups face added vulnerabilities.

What can we do to help?
  • Raise the conversation: Use the 16 Days as a prompt, organise workshops, social media posts, community dialogues to shift norms and reduce stigma.
  • Know the signs and support services: People need to know where to turn and that seeking help is safe and legitimate.
  • Promote prevention: Address underlying factors (gender inequality, harmful norms, lack of accountability) rather than only reacting to incidents.
  • Strengthen systems: Healthcare, justice, education and social protection systems must be equipped to respond effectively.
  • Tailor to context: In regions like West Africa, cultural, legal and service-access challenges may be especially significant. Localised interventions matter.
  • Engage men and boys: Ending gender-based violence is not only a ‘woman’s issue’, but a societal one. Men’s involvement, allyship, and behaviour change are essential.
During this period:
  • If you are a survivor or know someone affected, remember you are not alone. There are services, support networks and people willing to listen.
  • If you are a supporter (friend, family member, colleague), ask questions such as ‘are you safe?’, ‘what can I do to help?’, or offer your support by saying ‘you can always speak to me’.
  • In workplaces, schools, communities, consider dedicating time or resources to gender-based violence awareness, review policies, ensure safe reporting channels, and promote respectful relationships.
  • For decision makers, use this period to review and reinforce laws, service-delivery systems, data-collection and accountability mechanisms around gender-based violence.

The 16 Days of Activism exhort us to move beyond awareness alone. To prevention, support, accountability and structural change. Violence against women and girls is not an inevitable part of society, it is preventable. When we all act together, safer, more equitable spaces become attainable.

At Pharmalys, we stand with the global community in calling for an end to gender-based violence. We believe that every individual has the right to live in safety, dignity and equality.

Sources

https://www.unwomen.org/en/articles/explainer/five-essential-facts-to-know-about-femicide

https://www.unfpa.org/16days

https://www.un.org/en/delegate/16-days-activism-against-gender-based-violence

https://www.who.int/campaigns/16-days-of-activism-against-gender-based-violence/2024

https://www.emro.who.int/violence-injuries-disabilities/violence-news/16-days-of-activism-against-gender-based-violence.html

16 Days of Activism 2025: A Call to End Gender-Based Violence

16 Days of Activism 2025: A Call to End Gender-Based Violence

From 25 November to 10 December each year, the global community highlights the 16 Days of Activism Against Gender-Based Violence – a period dedicated to raising awareness, driving action and engaging all sectors of society to prevent and respond to violence rooted in...

Celebrating a Milestone in GCLP Compliance!

Celebrating a Milestone in GCLP Compliance!

We are thrilled to announce the successful completion of the initial GCLP accreditation audit at Hararghe Health Research Laboratory, Haramaya University College of Health and Medical Sciences, Harar, Ethiopia. The audit took place on 16–17 October 2025 and marked a...

Movember 2025: Raising Awareness for Men’s Health

Movember 2025: Raising Awareness for Men’s Health

November often signals the start of the festive season in many places, but for men’s health it holds a special significance: Movember. This annual campaign invites men (and those who support them) to pause, reflect and act on several critical health issues that too...

Highlights from the final Pharmalys Voice Meeting of 2025

Highlights from the final Pharmalys Voice Meeting of 2025

On September 25, 2025, Pharmalys held its third and final Pharmalys Voice meeting of the year, bringing together colleagues from across the company in a fun and interactive virtual gathering. The meeting involved presentations from colleagues, engaging discussions,...

Ethiopia Reaches WHO Maturity Level 3

Ethiopia Reaches WHO Maturity Level 3

On 3 October 2025, Dr Mekdes Daba, Health Minister of Ethiopia, announced a major achievement for the country: the formal recognition of the Ethiopian Food and Drug Authority (EFDA) as a Maturity Level 3 (ML3) regulatory system by the World Health Organization (WHO)....

Breast Cancer Awareness 2025: Access and Awareness Saves Lives

Breast Cancer Awareness 2025: Access and Awareness Saves Lives

Breast cancer remains the most common cancer among women worldwide. In the United States, statistics suggest that one in eight women will receive a diagnosis in her lifetime. In 2025 alone, it is estimated that 316,950 women and 2,800 men will be diagnosed with...